Koji Kurose
Kurashiki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Treatment Beyond Progressive Disease With Pazopanib for Cutaneous Angiosarcoma: A Case Report.
Journal: The Journal of dermatology
Published: December 09, 2025
Baseline Neutrophil-To-Lymphocyte Ratio as a Risk Stratification Marker for Severe Checkpoint Inhibitor Pneumonitis in Patients With Non-Small Cell Lung Cancer: A Two-Cohort Study With Retrospective Discovery and Prospective Validation.
Journal: Respirology (Carlton, Vic.)
Published: September 06, 2025
Phase I study on neoadjuvant combination immunotherapy with mogamulizumab and nivolumab for solid tumors.
Journal: Journal for immunotherapy of cancer
Published: March 14, 2025
The clinical potential of HMGB1 for the risk assessment of severe checkpoint inhibitor pneumonitis: A prospective multicenter study (CS-Lung004).
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 15, 2025
HMGB1 assists the predictive value of tumor PD-L1 expression for the efficacy of anti-PD-1/PD-L1 antibody in NSCLC.
Journal: Cancer chemotherapy and pharmacology
Published: August 29, 2024
Automated immunoassay of serum NY-ESO-1 and XAGE1 antibodies for predicting clinical benefit with immune checkpoint inhibitor (ICI) in advanced non-small cell lung cancer.
Journal: Cancer treatment and research communications
Published: May 12, 2024
Analysis of the relationship between comorbid obstructive sleep apnea and clinical outcomes in patients with asthma in Japan.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: September 16, 2023
Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers.
Journal: Advances in clinical chemistry
Published: January 15, 2023
Capillary-driven horseshoe vortex forming around a micro-pillar.
Journal: Journal of colloid and interface science
Published: December 07, 2022
Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migration inhibitor by an in vitro chemotaxis assay.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 19, 2022
Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitis.
Journal: Respirology (Carlton, Vic.)
Published: March 29, 2022
Last Updated: 09/26/2026